It does not reach the starting weight (in the first year) for those who lost more than 20% of body weight, and the gain seems to slow down over time - but it seems that a full weight re-gain is only a matter of time
If North Carolina is able to get a good deal, I dont know why other states wouldnt be able to participate in that. In 2023, Connecticut enacted a law requiring Medicaid to cover obesity treatment services
Physician-supervised protocols with pre-infusion bloodwork, individualized dosing, real-time drip-rate modulation, and follow-up labs at 4-8 weeks produce meaningfully different outcomes from generic IV bars that run high-dose infusions too fast, both for patient tolerability and clinical efficacy
[30] [31] A systematic review published in 2024 found that tirzepatide is well tolerated and not associated with pancreatitis, [32] but later case reports have found that pancreatitis followed initiation of treatment with tirzepatide
So, lets break down the difference between BPC-157 and CJC-1295 in simple terms